Cardiovascular and Soft Tissue Repair Patch Market, By Raw Material (ePTFE and Biomaterial and Tissue Engineered Material), By Application (Cardiac Repair, Soft Tissue Repair, Vascular Repair & Reconstruction, Pericardial Repair), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

The Global Cardiovascular and Soft Tissue Repair Patch Market is estimated to reach USD 7,610.5 billion by 2028 at a CAGR of 9.3% between 2020 and 2028. This growth is attributed due to the growing prevalence of congenital heart disorders such as atrial septal defect & ventricular septal defect and increasing technological advancements & R&D expenditure. Increasing prevalence of congenital heart diseases such as atrial septal defect and ventricular septal defect and technological advancements are the key driving factors for this market. Technological advancements have a multidimensional impact on new product development, product design, raw material fabrication, and clinical evaluation.

Fig 1: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET DRCO

Fig 1: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET DRCO

Increasing incidence of congenital diaphragmatic hernias, inguinal hernia, and others encourages the growth of the market as these patches are used for tissue repair procedures including soft tissue, dural & vascular repairs and reconstructions in the treatment of these disorders. An inguinal hernia, according to the National Institute of Diabetes and Digestive and Kidney Diseases, is a widespread condition across the world, affecting at lesast 27% of men and 3 percent of women at some stage in their lives. Furthermore, increasing collaboration between manufacturers and research organizations, government policy initiatives related to cardiac care, and the advancement of new technologies are few more factors that drive the growth of the cardiovascular and soft tissue repair patch market.

Fig 2: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY SEGMENTATION

Fig 2: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY SEGMENTATION

These patches are used in tissue repair procedures including soft tissue, dural and vascular repairs and reconstructions. Increasing prevalence of hernias such as congenital diaphragmatic hernias, inguinal hernia, and others are expected to positively impact the market growth. Repair of inguinal hernias is one of the most commonly performed general surgeries. As per the data published by the International Surgery Journal research article, in 2016, the rate of inguinal hernia repair surgeries in the U.S. was estimated at 28 per 100,000 people.

 

CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY RAW MATERIAL, 2019

Fig 3: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY RAW MATERIAL, 2019

By raw material, cardiovascular and soft tissue repair patches market is gets categories into biomaterial & tissue engineered material, and ePTFE. In terms of value, ePTFE accounted for the largest share of 62.8% of the global cardiovascular and soft tissue repair patches market, by raw material in 2019. This market is valued at USD XX million in 2020 nd is poised to grow at a CAGR of XX% during the forecast period to reach USD XX million by 2028. However, Biomaterial and Tissue Engineered Material segment expected to grow at highest CAGR of 10.2% over the forecast period to reach USD XX million by 2028.

CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY APPLICATION, 2019

Fig 4: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY APPLICATION, 2019

Based on application, global cardiovascular and soft tissue repair patches market segmented into cardiac repair, soft tissue repair, vascular repair & reconstruction, pericardial repair, and dural repair. In terms of value, Soft Tissue Repair accounted for the largest share of 35.1% of the global cardiovascular and soft tissue repair patches market, by application in 2019. This market is valued at USD XX million in 2020 and is poised to grow at a CAGR of 9.7% during the forecast period to reach USD XX million by 2028. However, Cardiac Repair segment expected to grow at highest CAGR of 10.9% over the forecast period to reach USD XX million by 2028.

CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY REGION, 2019     

Fig 5: CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET: BY REGION, 2019 

Based on Regional analysis, cardiovascular and soft tissue repair patches market segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. In terms of value, North America accounted for the largest share of 34.0% of the global cardiovascular and soft tissue repair patches market, by region in 2019. This market is valued at USD XX million in 2020 and is poised to grow at a CAGR of 8.1% during the forecast period to reach USD XX million by 2028. The key factors driving market growth in North American region are the presence of developed health-care infrastructure, the presence of key players and a large number of research activities. In addition, the increasing prevalence of cardiac diseases due to sedentary lifestyle, consumption of junk foods, alcohol, tobacco and substance abuse are some of the key factors that strengthen regional growth positively. However, Asia-Pacific is expected to witness the fastest growth of 12.7% during the forecast period to reach USD XX by 2028.

Key Developments

  • In February 2020, Terumo Launched New Surgical Sealant AQUABRID in EMEA Market. AQUABRID is indicated for use as an adjunct to standard methods of cardiovascular surgical repair to seal (such as sutures, staples, electrocautery, and/or patches) related to aorta surgery.
  • In January 2020, CorMatrix announced the first minimally invasive robotic implant of Cor PATCH.
  • In December 2019, CryoLife entered into an agreement whereby Misonix will have exclusive US commercialization rights for CryoLife's NeoPatch product to treat a broad range of indications outside of cardiac and vascular surgery.

Major Companies:  Major companies operating in the market includes Admedus, LeMaitre Vascular Inc., Baxter, Cryolife, Inc., CorMatrix, Inc, Abbott (St Jude Medical), B. Braun Melsungen AG, Terumo Medical Corporation, Integra LifeSciences Corporation, and Glycar SA Pty Ltd., and others.

Market Segmentation:

By Raw Material

  • ePTFE
  • Biomaterial and Tissue Engineered Material

By Application

  • Cardiac Repair
  • Soft Tissue Repair
  • Vascular Repair & Reconstruction
  • Pericardial Repair
  • Dural Repair

By Region:

  • North America Cardiovascular and Soft Tissue Repair Patch Market
    • By Country (US, Canada, Mexico)
    • By Raw Material
    • By Application
  • Europe Cardiovascular and Soft Tissue Repair Patch Market
    • By Country (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)
    • By Raw Material
    • By Application
  • Asia Pacific Cardiovascular and Soft Tissue Repair Patch Market
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Raw Material
    • By Application
  • Middle East & Africa Cardiovascular and Soft Tissue Repair Patch Market
    • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa)
    • By Raw Material
    • By Application
  • Rest of the World Cardiovascular and Soft Tissue Repair Patch Market
    • By Region (South America, Africa)
    • By Raw Material
    • By Application

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the cardiovascular and soft tissue repair patches market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the cardiovascular and soft tissue repair patches

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com